Takeda’s oveporexton (Orzeyful), a selective OX2R agonist, is the first therapy targeting orexin deficiency in NT1, improving ...

Fibrotic interstitial lung diseases, like idiopathic pulmonary fibrosis (IPF), commonly overlap with lung cancer—a key ...

Tozorakimab targets IL-33 upstream of TH2 pathways, cutting COPD exacerbations up to 34% in former smokers, Frank Sciurba, MD ...

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) suggests escalating treatment in patients with chronic ...

UK Biobank data linked 7-day wrist light sensing to CMR 3.1 years later, contrasting >3 lux nighttime exposure with none.

In "Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD," the mental health experts examined ...

While institutional resources such as financial counseling can help, she said such support is not available equally everywhere, and policy changes covering caregiver support and housing could have the ...

Standard echocardiographic criteria for grading tricuspid regurgitation (TR) may substantially underestimate the condition's ...

Yet H. Khor, MD, PhD, explains why the CPFE index can't replace CT imaging but may help triage which patients need scans. Emphysema extent of 20% or greater on CT imaging was associated with worse ...

Francesca Puggioni, MD, explains how real-world registry data, like the EU-ADVANTAGE study, informs regulatory decisions on ...

VHA/CMS screening identified 11,809 veterans with PV; after exclusions, 5,287 and 5,245 were analyzed for mortality and ...

In "Inside the Be Well Trials: Design, Population, and Patient Selection," the panel walks through why the Be Well trials ...